Iovance Biotherapeutics, Inc. (NASDAQ:IOVA – Get Free Report) was the recipient of a significant drop in short interest during the month of November. As of November 15th, there was short interest totalling 35,590,000 shares, a drop of 8.4% from the October 31st total of 38,860,000 shares. Approximately 18.0% of the company’s shares are short sold. […]
Iovance Biotherapeutics, Inc. (NASDAQ:IOVA – Get Free Report) saw some unusual options trading activity on Thursday. Traders acquired 30,658 call options on the stock. This represents an increase of approximately 518% compared to the typical volume of 4,963 call options. Iovance Biotherapeutics Stock Performance IOVA stock opened at $6.26 on Friday. The company’s 50 day […]
Panagora Asset Management Inc. lifted its stake in shares of Iovance Biotherapeutics, Inc. (NASDAQ:IOVA – Free Report) by 314.8% in the second quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 390,094 shares of the biotechnology company’s stock after acquiring an additional 296,053 shares during […]
Iovance Biotherapeutics, Inc. (NASDAQ:IOVA – Get Free Report) saw unusually large options trading on Thursday. Stock traders bought 30,658 call options on the company. This represents an increase of 518% compared to the average volume of 4,963 call options. Iovance Biotherapeutics Stock Performance IOVA traded up $0.39 during midday trading on Thursday, hitting $6.07. The […]
Harvest Investment Services LLC acquired a new position in shares of Iovance Biotherapeutics, Inc. (NASDAQ:IOVA – Free Report) during the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 124,943 shares of the biotechnology company’s stock, valued at approximately $880,000. Harvest […]